Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
The Department of Data Sciences at Dana-Farber Cancer Institute seeks a Lead Computational Biologist, to develop and implement cutting-edge technologies for cancer genomics and coordinate scientific projects at the Center for Cancer Genome Discovery (CCGD) at the Dana-Farber Cancer Institute. The primary mission of the CCGD is to facilitate genomic discoveries in human cancer samples through basic and translational cancer research using cutting-edge technologies. The CCGD has established platform groups to assist researchers in both genome-wide and gene-focused efforts using Illumina next generation sequencing. We strive to be at the forefront of cancer characterization, development and utilization of novel technologies, and adapting existing technologies for the advancement of cancer research. Technologies are selected and developed with a view to research-oriented ventures, as well as translational medicine and clinical relevance.
This exceptional opportunity offers the chance to work at the forefront of mutation discovery and translational cancer technologies and applications. The Lead Computational Biologist will oversee activities within CCGD informatics and manage technology development.
The primary responsibility of this role will be to lead the development and validation of multi-omic analytical methodologies for both cutting-edge research and clinical applications (such as development of analyses for liquid biopsies and structural variant detection). Working with scientific and clinical colleagues, the capabilities developed will be applied to precision cancer medicine efforts at our institutions. To make significant contributions to the research and clinical efforts described above, the candidate will have the ability to quickly arrive at innovative and effective solutions both as part of a team and independently.
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.